KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in KalVista Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 122
- +5 vs. Q2 2024
- Shares held
- 48.4M
- +3.19M (+7.1%) vs. Q2 2024
- Total value
- $561.0M
- +$28.2M (+5.3%) vs. Q2 2024
- New holders
- 18
- 49 more added
- Sold out
- 13
- 32 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Schroder Investment Management Group | 431,232 | $5.32M | 0.01% | −36,766−7.9% | Reduced |
| Saturn V Capital Management LLC | 556,489 | $6.44M | 2.30% | −571,989−50.7% | Reduced |
| Silverarc Capital Management, LLC | 574,558 | $6.65M | 1.50% | +13,675+2.4% | Added |
| Dimensional Fund Advisors LP | 607,036 | $7.03M | 0.00% | +72,057+13.5% | Added |
| Woodline Partners LP | 608,253 | $7.04M | 0.06% | +457,791+304.3% | Added |
| Emerald Mutual Fund Advisers Trust | 650,980 | $7.54M | 0.39% | +121,615+23.0% | Added |
| DAFNA Capital Management LLC | 723,678 | $8.38M | 1.98% | −83,295−10.3% | Reduced |
| Geode Capital Management, LLC | 830,984 | $9.62M | 0.00% | +24,713+3.1% | Added |
| Emerald Advisers, LLC | 835,988 | $9.68M | 0.37% | +192,091+29.8% | Added |
| MPM Oncology Impact Management LP | 896,915 | $10.4M | 1.56% | +14,978+1.7% | Added |
| State Street Corp | 1,271,609 | $14.7M | 0.00% | +515,179+68.1% | Added |
| Great Point Partners LLC | 1,299,503 | $15.0M | 4.54% | −39,065−2.9% | Reduced |
| Adage Capital Partners GP, L.L.C. | 1,419,792 | $16.4M | 0.03% | −630,208−30.7% | Reduced |
| Boxer Capital, LLC | 1,590,000 | $18.4M | 0.90% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,150,527 | $24.9M | 0.00% | +159,939+8.0% | Added |
| BlackRock, Inc. | 3,062,319 | $35.5M | 0.00% | +3,062,319 | New |
| Capital World Investors | 3,374,064 | $39.1M | 0.01% | +146,444+4.5% | Added |
| Frazier Life Sciences Management, L.P. | 3,687,867 | $42.7M | 1.71% | 00.0% | Unchanged |
| Vestal Point Capital, LP | 4,000,000 | $46.3M | 3.65% | +1,700,000+73.9% | Added |
| Suvretta Capital Management, LLC | 4,212,005 | $48.8M | 1.75% | +20,000+0.5% | Added |
| Tang Capital Management LLC | 4,321,547 | $50.0M | 3.57% | +102,718+2.4% | Added |
| VR Adviser, LLC | 6,249,731 | $72.4M | 3.79% | 00.0% | Unchanged |
| StemPoint Capital LP | 0 | $0 | 0.00% | −736,765−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −535,717−100.0% | Sold out |
| Perceptive Advisors LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −184,358−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −131,300−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −39,593−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −25,522−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −23,674−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −19,901−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −15,113−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −2,500−100.0% | Sold out |
| Innealta Capital, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −13−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |